Gilead Sciences Reports 28% Increase in Net Income
03 May 2019 - 6:49AM
Dow Jones News
By Robert Barba
Gilead Sciences Inc. (GILD) said Thursday its net income for the
first quarter rose 28% as revenue increased.
The biopharmaceutical company reported quarterly net income of
$1.98 billion, or $1.54 a share, compared with $1.54 billion, or
$1.17 a share, a year earlier.
Adjusted earnings were $1.76 a share, up from $1.48 a year
earlier.
Analysts polled by FactSet expected earnings of $1.26 a share
and adjusted earnings of $1.61 a share.
Revenue was $5.28 billion, up from $5.09 billion a year earlier.
Analysts expected revenue of $5.3 billion.
The company reiterated its full-year guidance, which calls for
net product sales of $21.3 billion to $21.8 billion.
Write to Robert Barba at robert.barba@wsj.com
(END) Dow Jones Newswires
May 02, 2019 16:34 ET (20:34 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2024 to May 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2023 to May 2024